Thank you
This live web event has ended. Thank you for attending.
Description
The IASP 2022 World Congress on Pain took place from 19-23 September 2022, in Toronto, Canada. As IASP prepares to release recordings of the World Congress' Plenary Lectures and select Topical Workshops, we are excited to bring you this accompanying webinar. Continuing Medical Education (CME) credits will be available to those who attend.
Attendance is free for IASP members, though registration is still required. A registration fee of $25 is required for non-IASP members. To become an IASP member, you can join here. Trainee memberships are $50 per year, while regular memberships are $180 or $230 per year, depending on income level.
Pain and Opioids in Early Life: Long-Term Consequences for Pain Sensitivity and Neurodevelopment
The last decades have seen a growing number of infants - especially those born preterm - exposed to pain in early life. While it is now widely recognized that newborn infants are capable of experiencing pain, this vulnerable population receives 7-17 painful exposures daily - with less than half associated with any form of pain relief.
Research has focused on optimizing treatment to diminish the immediate physiological response to pain. In neonates, however, early life exposure to opioids (either pre- or postnatally) - and subsequent opioid withdrawal - lead to discomfort with acute signs like tremors, excessive crying, reduced feeding, and even seizures.
It is well established that exposure to pain and opioids in early life leads to long-lasting alterations in pain sensitivity, brain development, cognitive functioning, and response to analgesia. In this session, expert panelists will guide the audience through existing and novel insights into the effects of pain and opioid exposure in early life. By discussing both clinical and preclinical evidence, this workshop will give a comprehensive and translational overview of where the field currently stands, and where the next big steps should be made.
Participants include:
-- Nynke J. van den Hoogen, PhD, Hotchkiss Brain Institute, University of Calgary, Canada
Opioid Exposure and Withdrawal in Early Life: Preclinical Evidence into Mechanisms and Long-Term Consequences
-- Manon Ranger, PhD, School of Nursing, University of British Columbia, Canada
Signature of Pain and Stress Exposure in Very Preterm Infants
-- Ricardo Carbajal, MD, PhD, Hospital Trousseau, Sorbonne University, France
Neurodevelopmental Effects of Neonatal Pain: Clinical Data
Learning Objectives:
1) Interpret the acute and lasting impact of pain and opioid exposure in early-life, and the intricate interplay between pain and analgesia in this vulnerable population.
2) Describe how exposure to early-life pain and opioids alters neurodevelopment.
3) Apply knowledge translation strategies related to early-life pain and opioid exposure.